Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine

Journal of Association of Physicians of India

Volumn 51, Issue JUL, 2003, Pages 655-658

  Deshpande, Alaka K ^a   Londhe, V A ^a   Akarte, Sulabha ^c   Briggs, Deborrah ^b  

^a GRANT MEDICAL COLLEGE   (India)

^b UNIVERSITY OF KANSAS   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE; VIRUS ANTIBODY;

ADULT; AGED; ANIMAL; ARTICLE; BITES AND STINGS; BLOOD; CHICK EMBRYO; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROL GROUP; DOG; HUMAN; IMMUNIZATION; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; PASSIVE IMMUNIZATION; RABIES; RABIES VIRUS; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; VACCINATION;

ADULT; AGED; ANIMALS; ANTIBODIES, VIRAL; BITES AND STINGS; CHICK EMBRYO; CONTROL GROUPS; DOGS; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, PASSIVE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; RABIES; RABIES VACCINES; RABIES VIRUS; SEX FACTORS; TIME FACTORS; VACCINATION;

EID: 2842609375     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. T Jacob John. An Ethical dilemma in rabies prophylaxis. Vaccine 1997;15(suppl):S12-S15.
2. Dutta AK, Kanwal SN. Rabies and its prevention. J APCRI 1999;1:5-13.
3. Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Morser AB, Phanupak P. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. NEJM 1987;316:369-73.
4. Manjula Natarajan P, Mukundan, Jacob John. Immune response to PCECV. Indian J Med Res 1992;95:51-3.
5. Briggs DJ. PCECV: Rabies vaccine for a new millennium. J APCRI 2000;1:26-9.
6. WHO TRS No. 1984;709:28-34.
7. Smith JS, Yagee PA, Baee GM. RFFIT for determining rabies virus-neurtalizing antibody. Laboratory Techniques in Rabies: CH. 1990;15:181-9.
8. Dutta JK. Rabies prevention; Cost to an Indian labourer. JAMA 1996;226-32.
9. Lang J, Attanah P, Quiambao B. Evaluation of safety, immunogenecity of ERIG and PVRV. Acta Tropica 1998;70:317-33.
10. Hanlon CA, Niezgodas M. The incurable wound revisited: Progress in human rabies prevention. Vaccine 2001;19:2273-9.
11. Tuncman ZM. Rabies without bite. Turk Tip Cen Mec 1946;12:60-4.
12. Ananthanarayan R, Panicker CKJ. In : Textbook of Microbiology, Orient Longman Rhabdoviruses, Sixth Edition 2000 (Reprint 2001), 496-506.
13. Leach CN, Johnson HN. Human rabies with special reference to virus. Am J Tropical Med 1940;20:335-40.
14. Sehgal S, et al. Clinical evaluation of PCECV in Healthy volunteers. J Comm Disease 1988;20:247-52.
15. Nicholson KG, et al. Pre-exposure studies with PCECV and HDCV: Serological and clinical response in man. Vaccine 1998;5:208.
16. Selvakumar R, Jocob John T. Immune response to PCECV in dog bite victims. Indian Journal Med Res 1989;217-20.
17. Barth R, Gruschkau H, Bijok U, et al. A new inactivated tissue culture rabies vaccine for use in man. Evaluation of PCECV by lab. Tests. J Biol Stand 1984;12:29-46.
18. Barth R, Bijok U, Gruschkau H, Smerdel J, Vodopija J. Purified chicken embryo cell rabies vaccine for human use. Lancet 1983;26, 1 (8326 Pt 1) : 700.
19. Wasi C, Chaiprasithikul P, Chavanich L, Puthavathana P, Thongcharoen P, Trishananda M. Purified chick embryo cell rabies vaccine. Lancet 1986;4;1(8471):40.
20. Khare KC, Mathew V. Rabies prevention: Current schedules and available vaccines. Indian Practioner 2001;54:181-7.